Catalytic mechanism for Renilla-type luciferasesAndrea Schenkmayerová, Martin Marek, David Bednář et al.|Nature Catalysis|2023Cited by 65
Hidden Potential of Highly Efficient and Widely Accessible Thrombolytic StaphylokinaseMartin Toul, Zbyněk Prokop, David Bednář et al.|Stroke|2022Cited by 12
Identification, characterization, and engineering of glycosylation in thrombolyticsMartin Toul, Zbyněk Prokop, David Bednář et al.|Biotechnology Advances|2023Cited by 9
Computer-aided engineering of staphylokinase toward enhanced affinity and selectivity for plasminDmitri Nikitin, Martin Marek, David Bednář et al.|Computational and Structural Biotechnology Journal|2022Cited by 8
Biochemical and Immunological Properties of Engineered Low-Immunogenic Staphylokinases for Next-Generation Thrombolytic TherapyAlan Strunga, David Bednář, Jiřı́ Damborský et al.|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0